Novartis Ag Adr (NVS)

Mar 27, 2026

Novartis Bolsters Immunology Pipeline With Excellergy Deal - Zacks Investment Research

Mar 27, 2026

Mar 27, 2026

Novartis Bets $2 Billion To Deepen Allergy Drug Pipeline - Benzinga

Mar 27, 2026

Mar 27, 2026

Novartis to acquire Excellergy, strengthening allergy pipeline with next-generation anti-IgE therapy - Proactive financial news

Mar 27, 2026

Mar 27, 2026

Novartis AG Stock: Strong Analyst Upgrades and Pipeline Momentum Drive Investor Interest in 2026 - AD HOC NEWS

Mar 27, 2026

Mar 26, 2026

Novartis AG (NVS) Bonds - GuruFocus

Mar 26, 2026

Mar 26, 2026

Novartis AG stock gains 2% on SIX Swiss Exchange amid strong SMI performance and positive pharma sec - AD HOC NEWS

Mar 26, 2026

Mar 24, 2026

Novartis AG stock surges on Bank of America price target hike amid strong pharma pipeline momentum - AD HOC NEWS

Mar 24, 2026

Mar 23, 2026

Novartis AG Stock Faces Pressure Amid Multi-Billion Oncology Acquisition and Pipeline Advances - AD HOC NEWS

Mar 23, 2026

Mar 23, 2026

NVS Stock Price, Quote & Chart | NOVARTIS AG-SPONSORED ADR (NYSE:NVS) - ChartMill

Mar 23, 2026

Mar 22, 2026

Novartis AG Stock Gains Traction on Analyst Upgrades and Oncology Pipeline Momentum in 2026 - AD HOC NEWS

Mar 22, 2026

Mar 20, 2026

Novartis AG stock dips on Swiss Exchange amid $3B breast cancer drug acquisition announcement - AD HOC NEWS

Mar 20, 2026

Mar 20, 2026

Novartis Strikes $3 Billion Deal For Next-Gen Breast Cancer Drug - Sahm

Mar 20, 2026

Mar 20, 2026

Novartis agrees to acquire a pan-mutant-selective PI3Kα inhibitor, strengthening its breast cancer pipeline - ChartMill

Mar 20, 2026

Mar 16, 2026

NVS Stock Quote Price and Forecast - CNN

Mar 16, 2026

Mar 15, 2026

Novartis AG Stock (ISIN: CH0012005267) Holds Steady Amid Analyst Upgrades and Pipeline Momentum - AD HOC NEWS

Mar 15, 2026

Mar 15, 2026

Novartis AG Stock (ISIN: CH0012005267) Holds Steady Amid Analyst Upgrade and Portfolio Shifts - AD HOC NEWS

Mar 15, 2026

Mar 14, 2026

Novartis AG Stock (ISIN: CH0012005267) Holds Steady Amid Pharma Sector Shifts - AD HOC NEWS

Mar 14, 2026

Mar 13, 2026

Novartis Cosentyx® receives FDA approval for pediatric patients aged 12+ with moderate to severe hidradenitis suppurativa - ChartMill

Mar 13, 2026

Mar 13, 2026

Novartis AG-Sponsored ADR (NYSE:NVS): A Methodical Pick for Steady Dividend Income - ChartMill

Mar 13, 2026

Mar 11, 2026

Novartis slides as shares trade ex-dividend for annual payout - Quiver Quantitative

Mar 11, 2026

Mar 10, 2026

Novartis shareholders approve all resolutions proposed by the Board of Directors at the 2026 Annual General Meeting - Novartis

Mar 10, 2026

Mar 06, 2026

Novartis successfully completes acquisition of Avidity Biosciences, strengthening late-stage neuroscience pipeline and advancing xRNA strategy - Novartis

Mar 06, 2026

Mar 05, 2026

Skeletal Dysplasia Market - GlobeNewswire Inc.

Mar 05, 2026

Mar 02, 2026

What's Driving the Market Sentiment Around Novartis AG? - Sahm

Mar 02, 2026

Feb 28, 2026

Novartis Stock: Can New Cancer Bets Keep Beating Big Pharma? - AD HOC NEWS

Feb 28, 2026

Feb 28, 2026

Novartis (NVS) Announces Plans to Establish a New Radioligand Therapy Manufacturing Site in Denton, Texas - Finviz

Feb 28, 2026

Feb 26, 2026

Avidity Biosciences shareholders approve merger with Novartis - Investing.com

Feb 26, 2026

Feb 25, 2026

Novartis stock hits all-time high at 167.87 USD - Investing.com

Feb 25, 2026

Feb 25, 2026

Novartis stock hits all-time high at 167.87 USD By Investing.com - Investing.com UK

Feb 25, 2026

Feb 20, 2026

Novartis India shares surge after Swiss parent agrees $159 mln exit deal - Investing.com

Feb 20, 2026

Feb 19, 2026

Stocks To Watch, February 20: Swiggy, IT stocks, crude-sensitive stocks, Novartis India, ABB India, CIE Automotive, Zydus Life - Upstox

Feb 19, 2026

Feb 19, 2026

Where is Novartis AG (NVS) Headed? - Finviz

Feb 19, 2026

Feb 19, 2026

Nature - Novartis

Feb 19, 2026

Feb 19, 2026

Novartis AG-Sponsored ADR (NYSE:NVS): A Quality Dividend Stock with Strong Fundamentals - ChartMill

Feb 19, 2026

Feb 18, 2026

Itchy Skin Conditions? Novartis' Pivotal Trial Success Shows Potential For Targeted Relief - Sahm

Feb 18, 2026

Feb 17, 2026

A Look Into Novartis Inc's Price Over Earnings - Sahm

Feb 17, 2026

Feb 16, 2026

Novartis AG stock reaches all-time high at 160.21 USD - Investing.com Nigeria

Feb 16, 2026

Feb 13, 2026

Novartis AG stock reaches all-time high at 160.21 USD By Investing.com - Investing.com South Africa

Feb 13, 2026